牛牛AI助理已提取核心訊息
CVS Health Corporation officer Prem S Shah is set to sell 29,473 shares of common stock on 02/16/2024, with an aggregate market value of $2,267,923.77. The shares to be sold were acquired through various means, including Dividend Reinvestment Plans (DRIP), Employee Stock Purchase Plans, and restricted stock vesting under registered plans, with acquisition dates ranging from 2020 to 2024. The transactions involved both cash payments and services rendered as forms of payment. This planned sale follows a period where no securities were sold in the past three months, as per the latest available data.
CVS Health Corporation officer Prem S Shah is set to sell 29,473 shares of common stock on 02/16/2024, with an aggregate market value of $2,267,923.77. The shares to be sold were acquired through various means, including Dividend Reinvestment Plans (DRIP), Employee Stock Purchase Plans, and restricted stock vesting under registered plans, with acquisition dates ranging from 2020 to 2024. The transactions involved both cash payments and services rendered as forms of payment. This planned sale follows a period where no securities were sold in the past three months, as per the latest available data.
CVS Health Corporation高管Prem S Shah定於2024年2月16日出售29,473股普通股，總市值爲2,267,923.77美元。待售股票是通過各種方式收購的，包括股息再投資計劃（DRIP）、員工股票購買計劃和註冊計劃下的限制性股票歸屬，收購日期從2020年到2024年不等。這些交易既涉及現金支付，也涉及作爲付款方式提供的服務。根據最新的可用數據，此次計劃出售是在過去三個月中沒有出售證券的時期之後進行的。
CVS Health Corporation高管Prem S Shah定於2024年2月16日出售29,473股普通股，總市值爲2,267,923.77美元。待售股票是通過各種方式收購的，包括股息再投資計劃（DRIP）、員工股票購買計劃和註冊計劃下的限制性股票歸屬，收購日期從2020年到2024年不等。這些交易既涉及現金支付，也涉及作爲付款方式提供的服務。根據最新的可用數據，此次計劃出售是在過去三個月中沒有出售證券的時期之後進行的。
有用
沒用